Go Back to Match Results for ""

A Multicenter Randomized Double Blind Placebo Controlled Parallel Group Pilot Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects with Relapsing-remitting Multiple Sclerosis
Study Overview
The purpose of this study is to examine the safety, tolerability and response rate of Acthar in subjects with RRMS who have not responded to high dose intravenous methylprednisolone (IVMP), oral prednisone, or oral methylprednisolone.
Study Description
The purpose of this study is to examine the safety, tolerability and response rate of Acthar in subjects with Relapsing-remitting multiple sclerosis (RRMS) who have not responded to high dose intravenous methylprednisolone, oral prednisone, or oral methylprednisolone.
Additional Information
Participants will be compensated for their participation.
- IRB Number: 1706802372
- Research Study Identifier: TX8265
- Principal Investigator: Jaison Grimes, MD
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required